Akebia reports Q3 2026 results as Vafseo patient count grows and VOICE, VOCAL data landNov 5Quarterly updateAkebia Therapeuticsvadadustat
Akebia reports Q2 2026 results, VOICE interim data, and new ebribafusp trialAug 5Quarterly updateAkebia Therapeuticsvadadustat
Akebia and USRC halt VOICE trial early after Vafseo beats ESA on safetyJun 30Clinical readoutAkebia Therapeuticsvadadustat